Amprius Technologies (NYSE:AMPX) Trading Down 27.3% on Disappointing Earnings

Amprius Technologies, Inc. (NYSE:AMPX)’s share price fell 27.3% during mid-day trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $15.38 and last traded at $16.1230. 30,385,129 shares changed hands during mid-day trading, an increase of 243% from the average session volume of 8,860,231 shares. The stock had previously closed at $22.19.

The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The company had revenue of $28.54 million during the quarter, compared to the consensus estimate of $25.72 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS.

More Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Q1 revenue growth materially exceeded expectations — revenue was $28.5M (up ~2.5x year?over?year), and net loss narrowed versus a year ago, supporting the case for commercial traction and improving fundamentals. Amprius Q1 results & highlights
• Positive Sentiment: The company reached agreements to exchange certain public warrants for common stock to simplify its capital structure, which can remove an overhang of outstanding warrants if managed without excessive dilution. Amprius to Simplify Capital Structure Through Exchange of Public Warrants
• Positive Sentiment: New market products tied to AMPX — Defiance launched a 2x long single?stock ETF (AMPU) — could increase investor access and trading interest, potentially improving liquidity and attracting momentum traders. Defiance Launches AMPU
• Positive Sentiment: Recent analyst/coverage pieces highlight a path to improved margins and commercial inflection, providing bullish narrative for longer?term holders. Amprius Ups the Voltage on Forward Outlook
• Neutral Sentiment: FY?2026 EPS guidance was reiterated at roughly -$0.06, in line with consensus — provides visibility but keeps profitability timeline negative for the year. Amprius Q1 press release (guidance)
• Negative Sentiment: EPS missed estimates — reported a ($0.04) loss vs. consensus ($0.02) — which likely triggered short?term selling and raised concerns about near?term profitability despite the revenue beat. AMPX Reports Q1 Loss, Beats Revenue Estimates
• Negative Sentiment: Shares had a very strong multi?month run (large year?to?date gains), making the stock vulnerable to profit?taking after mixed results; the new leveraged ETF also increases short?term volatility and can exacerbate moves. Is It Too Late To Consider Amprius?

Analysts Set New Price Targets

A number of equities analysts have weighed in on AMPX shares. Roth Mkm reaffirmed a “buy” rating and set a $20.00 target price (up from $16.00) on shares of Amprius Technologies in a research note on Friday, March 6th. Craig Hallum raised their target price on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Friday, March 6th. William Blair reaffirmed an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research note on Monday, April 20th. Finally, B. Riley Financial raised their target price on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, March 9th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Insider Activity

In other news, Director Kang Sun sold 1,500,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the sale, the director owned 1,342,400 shares in the company, valued at $21,357,584. This represents a 52.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Steven Chu sold 155,565 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the sale, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 2,539,829 shares of company stock worth $42,323,376. Corporate insiders own 12.90% of the company’s stock.

Institutional Investors Weigh In On Amprius Technologies

A number of institutional investors have recently made changes to their positions in the company. AlphaCentric Advisors LLC boosted its holdings in Amprius Technologies by 20.0% in the first quarter. AlphaCentric Advisors LLC now owns 60,000 shares of the company’s stock worth $1,012,000 after purchasing an additional 10,000 shares during the last quarter. KBC Group NV purchased a new stake in Amprius Technologies in the first quarter worth approximately $57,000. Swiss National Bank boosted its holdings in Amprius Technologies by 4.7% in the first quarter. Swiss National Bank now owns 232,400 shares of the company’s stock worth $3,918,000 after purchasing an additional 10,400 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Amprius Technologies by 700.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company’s stock worth $6,695,000 after purchasing an additional 377,485 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in Amprius Technologies by 60.9% in the first quarter. Geneos Wealth Management Inc. now owns 17,140 shares of the company’s stock worth $289,000 after purchasing an additional 6,490 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company’s stock.

Amprius Technologies Stock Down 27.3%

The company’s fifty day moving average is $17.43 and its 200-day moving average is $13.22. The company has a market cap of $2.21 billion, a PE ratio of -47.42 and a beta of 2.20.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.